BioCentury
ARTICLE | Clinical News

Lytix Biopharma AS preclinical data

September 24, 2007 7:00 AM UTC

In mice, LTX-9 had activity against both Gram-positive and -negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The company hopes to submit an IND for the anti-microbial i...